Jeffrey A. Meckler

Companies

• Indaptus Therapeutics, Inc.Board member Aug 2, 2021 to now¹
• Travere Therapeutics, Inc.Board member Oct 10, 2014 to now²
• Indaptus Therapeutics, Inc.Chief executive officer Aug 2, 2021 to Dec 23, 2025¹
• Cocrystal Pharma, Inc.Chief executive officer Oct 2, 2015 to Mar 17, 2016³
• Cocrystal Pharma, Inc.Board member Dec 5, 2014 to Mar 17, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX91,500 shares⁵$4.6M at $50.55Sep 10, 2026
• ITIndaptus Therapeutics, Inc. INDP229,929 shares⁶$639.2K at $2.78Dec 22, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 10, 2026Sold 3,100 shares at $68.09 of Travere Therapeutics, Inc.⁵
• Sep 10, 2026Sold 14,000 shares at $67.46 of Travere Therapeutics, Inc.⁵
• Sep 10, 2026Sold 1,200 shares at $66.15 of Travere Therapeutics, Inc.⁵
• Sep 10, 2026Sold 1,700 shares at $65.39 of Travere Therapeutics, Inc.⁵
• Sep 10, 2026Exercised options 10,000 shares at $26.52 of Travere Therapeutics, Inc.⁵
• Sep 10, 2026Exercised options 10,000 shares at $17.44 of Travere Therapeutics, Inc.⁵
• May 19, 2026Granted 4,000 shares of Travere Therapeutics, Inc.⁷
• May 4, 2026Sold 8,000 shares at $45.00 of Travere Therapeutics, Inc.⁸
• May 4, 2026Exercised options 8,000 shares at $16.33 of Travere Therapeutics, Inc.⁸
• Dec 22, 2025Granted 216,617 shares at $2.03 of Indaptus Therapeutics, Inc.⁶
• Jul 27, 2025Granted 6,068 shares at $8.30 of Indaptus Therapeutics, Inc.⁹
• May 15, 2025Granted 6,500 shares of Travere Therapeutics, Inc.¹⁰
• Nov 25, 2024Granted 42,553 shares at $1.18 of Indaptus Therapeutics, Inc.¹¹
• Sep 30, 2024Sold 40,000 shares at $14.06 of Travere Therapeutics, Inc.¹²
• Sep 30, 2024Exercised options 40,000 shares at $10.48 of Travere Therapeutics, Inc.¹²
• Aug 8, 2024Granted 84,932 shares at $1.83 of Indaptus Therapeutics, Inc.¹³
• May 8, 2024Granted 6,500 shares of Travere Therapeutics, Inc.¹⁴
• May 17, 2023Granted 4,500 shares of Travere Therapeutics, Inc.¹⁵
• Nov 21, 2022Bought 9,600 shares at $1.90 of Indaptus Therapeutics, Inc.¹⁶
• Nov 18, 2022Bought 400 shares at $1.76 of Indaptus Therapeutics, Inc.¹⁶
• Sep 8, 2022Bought 10,308 shares at $2.80 of Indaptus Therapeutics, Inc.¹⁷
• Sep 7, 2022Bought 8,632 shares at $2.57 of Indaptus Therapeutics, Inc.¹⁸
• Sep 6, 2022Bought 1,060 shares at $2.44 of Indaptus Therapeutics, Inc.¹⁸
• Jun 6, 2022Bought 19,727 shares at $2.63 of Indaptus Therapeutics, Inc.¹⁹
• May 11, 2022Granted 3,000 shares of Travere Therapeutics, Inc.²⁰